Renal Function and NODM in De Novo Renal Transplant Recipients Treated with Standard and Reduced Levels of Tacrolimus in Combination with EC-MPS
Figure 2
Incidence of new onset diabetes mellitus at month 3, 6, and overall (safety population Group A, ; Group B, ). NODM = patients treated for hyperglycemia for a period of 14 consecutive days, or had 2 h OGTT posttest value ≥200 mg/dL, or had at least two fasting glucose values ≥126 mg/dL, or had one single random value (fasting or nonfasting) ≥mg/dL. Safety population, patients with diabetes mellitus active at start of study, was excluded.
